Revvity to acquire Human Cell Design
Engineered immune cells trial to fight colorectal cancer approved
Elix and Axcelead DDP to collaborate on targeted protein degrader discovery
Lotus Neuro launches to deliver therapies across blood-brain barrier
Ryght AI and Biorasi to partner on AI
Novel gene therapy for ALS cleared for trials in US and China
Researchers re-engineer AI language model to target previously ‘undruggable’ disease proteins
KAIST develops AI that automatically designs optimal drug candidates for cancer-targeting mutations
Base to Base biotech podcast 21: Elix drug discovery platform and CytoAgents on CAR-T, CRS and the FDA
Base to Base biotech podcast 18: NETs and AI to tackle antimicrobial resistance
Base to Base biotech podcast 16: Domain Therapeutics, SandboxAQ and LinkGevity
I-Corps Hub West accelerates deeptech commercialisation in western US